Therefore, we performed GATA2 IHC on metastatic tumors collected at staging hysterectomy from 22 patients in our UW1 cohort and compared their expression to the primary tumor to determine if USC metastases have different GATA2 levels than the primary tumors (Supplemental Figure 8). Here, GATA2 is linked to metastatic neoplasm.